Max Portfolio Pct.
Check
Valuation
Check
Stock Quality:
Max Portfolio Pct.
Check
Valuation
Check
TMO Price Action
Last 7 days
-4.8%
Last 30 days
-11.1%
Last 90 days
-29.5%
Trailing 12 Months
-30.2%
TMO RSI Chart
TMO Valuation
TMO Price/Sales (Trailing)
The Good, Bad and Ugly
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
TMO Fundamentals
TMO Revenue
TMO Earnings
TMO Profitability
TMO Investor Care
TMO Alerts
Revenue & Growth
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2025 | 42.9B | 0 | 0 | 0 |
| 2024 | 42.5B | 42.3B | 42.4B | 42.9B |
| 2023 | 43.8B | 43.5B | 43.4B | 42.9B |
| 2022 | 41.1B | 42.8B | 44.2B | 44.9B |
| 2021 | 35.9B | 38.3B | 39.1B | 39.2B |
| 2020 | 25.6B | 26.2B | 28.5B | 32.2B |
| 2019 | 24.6B | 24.9B | 25.2B | 25.5B |
| 2018 | 22.0B | 23.1B | 23.9B | 24.4B |
| 2017 | 18.7B | 19.2B | 19.8B | 20.9B |
| 2016 | 17.3B | 17.6B | 18.0B | 18.3B |
| 2015 | 16.9B | 16.9B | 16.8B | 17.0B |
| 2014 | 13.8B | 14.9B | 15.9B | 16.9B |
| 2013 | 12.6B | 12.8B | 12.9B | 13.1B |
| 2012 | 11.9B | 12.2B | 12.3B | 12.5B |
| 2011 | 10.5B | 10.8B | 11.1B | 11.6B |
| 2010 | 0 | 10.4B | 10.5B | 10.4B |
Get all data in R, Python etc through our Historical Stock Data APIs
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, laboratory chemicals, research and safety market channel, and pharma services and clinical research. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
| CEO | Mr. Marc N. Casper |
|---|---|
| WEBSITE | thermofisher.com |
| SECTOR | Healthcare |
| INDUSTRY | Diagnostics & Research |
| EMPLOYEES | 65535 |
